Flagella as a platform for epitope-based vaccines

Israel Medical Association Journal

Volumn 8, Issue 5, 2006, Pages 316-318

  Ben Yedidia, Tamar ^a   Arnon, Ruth ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Epitope; Flagella; Influenza; Peptide; Schistosoma mansoni; Vaccine

Indexed keywords

EPITOPE; FLAGELLIN; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 12; RECOMBINANT FLAGELLA 9B PEPTIDE; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE; SCHISTOSOMA VACCINE; TOLL LIKE RECEPTOR 5; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CELL TRANSPLANTATION; DRUG DESIGN; DRUG SAFETY; DRUG TOLERABILITY; EXPRESSION VECTOR; FEASIBILITY STUDY; FLAGELLUM; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; RADIATION CHIMERA; SALMONELLA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE; VACCINE PRODUCTION; VIRUS LOAD;

ANIMALS; EPITOPES; FLAGELLIN; HUMANS; ORTHOMYXOVIRIDAE; SALMONELLA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES;

EID: 33744502352     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hwang Y, Kim N, Park J, et al. HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo. Vaccine 2002;20:3770-7.
2. Knutson K, Schiffman K, Disis M. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. J Clin Invest 2001;107:477-84.
3. Takahashi T, Tanaka Y, Nieda M, et al. Dendritic cell vaccination for patients with chronic myelogenous leukemia. Leuk Res 2003;27:795-802.
4. Focke M, Mahler V, Ball T, et al. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J 2001;15:2042-4.
5. Smith B, Reina-Guerra M, Hoiseth S, Stocker B, Habasha F, Merritt F. Aromatic-dependent Salmonella typhimurium as modified live vaccines for calves. Am J Vet Res 1984;45:59-66.
6. Newton S, Jacob C, Stocker B. Immune response to cholera toxin epitope inserted in Salmonella flagellin. Science 1989;244:70-2.
7. Hayashi F, Smith K, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-103.
8. Tognon M, De Giuli Morghen C, Radaelli A, Stocker B, Cattozzo E. Expression and immunogenicity of V3 loop epitopes of HIV-1, isolates SC and WMJ2, inserted in Salmonella flagellin. J Biotechnol 1997;56:191-203.
9. Verma N, Weir R, Lee E, Whittle B. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella. J Med Microbiol 1997;46:129-38.
10. Ferreira L, Abrahamsohn I, Massis L, Mosca T, Sbrogio-Almeida M. Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains. Infect Immun 2004;72:2546-55.
11. Bergquist NR. Controlling schistosomiasis by vaccination: a realistic opinion? Parasitol Today 1995;11(5):191-4.
12. Capron A, Riveau G, Capron M, Trottein F. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005;21:143-9.
13. Tarrab-Hazdai R, Levi-chaffer F, Brenner V, Horowitz S, Eshhar Z, Arnon R. Protective mooconal antibodies against Schistosoma mansoni. Antigen isolation, characterization and suitability for active immunization. J Immunol 1985;135(4):2772-9.
14. Tarrab-Hazdai R, Schechtman D, Lowell G, Pirak E, Arnon R. Proteosome delivery of a protective 9B-antigen against Schistosoma mansoni. Int J Immunopharmacol 1999;21(3):205-18.
15. Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R. Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni. Infect Immun 1999;67:4360-6.
16. Levi R, Arnon R. Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection. Vaccine 1996;14:85-92.
17. Ben-Yedidia T, Abel L, Arnon R, Globerson A. Efficacy of anti-influenza peptide vaccine in aged mice. Mech Ageing Dev 1998;104:11-23.
18. Lubin I, Segall H, Marcus H, et al. Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood 1994;83:2368-81.
19. Ben-Yedidia T, Marcus H, Reisner Y, Arnon R. Intranasal adminstration of peptide vaccine protects human/mouse radiation chimera from influenza infection. Int Immunol 1999;11:1043-51.